Taken all together, these results indicate that inhibiting SKI-1/S1P can interrupt the HCV lifecycle at multiple stages of viral infection both preventing naïve cells from becoming infected and preventing virus release from already infected cell populations. Here, MBTPS1 is linked to viral infectious disease.